Filing Details

Accession Number:
0001178913-18-001826
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-31 16:51:10
Reporting Period:
2018-05-13
Accepted Time:
2018-05-31 16:51:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1606645 Foamix Pharmaceuticals Ltd. FOMX Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1727864 Stanley Hirsch C/O Foamix Pharmaceuticals Ltd.
2 Holtzman Street
Rehovot L3 7670402
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-05-13 6,224 $5.04 12,672 No 4 X Direct
Ordinary Shares Disposition 2018-05-13 6,164 $5.09 6,508 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Warrants (right to buy) Disposition 2018-05-13 6,224 $0.00 6,224 $5.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-05-14 2018-05-13 No 4 X Direct
Footnotes
  1. On May 13, 2018, warrants held by Mr. Hirsch for the purchase of up to 6,224 ordinary shares of the Issuer for $5.04 per share were automatically exercised on a net-issuance (cashless) basis upon their expiration, in accordance with their terms. This cashless exercise resulted in the Issuer withholding 6,164 of the warrant shares to pay the exercise price and issuing to Mr. Hirsch the remaining 60 shares.